ILD Case Library: Learn to Manage Patients with IPF, PF-ILD, SSc-ILD, and post-COVID-19 Infections

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by The France Foundation.

 

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Credit Available

• Physicians — maximum of 1.5 AMA PRA Category 1 Credit(s)™
• Nurses — 1.5 total contact hour(s) of continuing nursing education

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for pulmonologists, rheumatologists, dermatologists, primary care providers, respiratory nurses/nurse practitioners/physician assistants, and other health care providers who may be involved in the management of patients with ILD.

Program Overview

This activity will cover pulmonary disease.

Learning Objectives

Upon completion of this activity, participants should be better able to:

• Identify the ILDs most commonly associated with a progressive fibrosis phenotype
• Use clinical impression and appropriate diagnostic tests to diagnose (and differentially diagnose) SSc-ILD
• Involve multiple specialists, nurses, advanced practice providers, and therapists in coordination of care of patients with IPF from the standpoint of diagnosis, treatment, management of comorbidities, and optimization of patient well-being (e.g., pulmonary rehabilitation)
• Manage patients with IPF proactively and effectively during the COVID-19 pandemic
• Review the therapeutic options for the management of SSc-ILD
• Apply an individualized treatment approach to patients with SSc-ILD
• Evaluate non-PF-ILD COVID patients for fibrotic changes in the lungs after recovery

Faculty

Nurse Planner:

Khamini Guillermo, DNP, CRNP, MSN

Nurse Practitioner
Ursinus College Student Health Center
Collegeville, PA

Physician Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation

The France Foundation designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit

Nurses

This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.

Disclosures of Conflicts of Interest

The faculty listed below report that they have no relevant financial relationships to disclose:

• Joseph Barney, MD, MSPH, FCCP
• Khamini Guillermo, DNP,CRNP
• Vikramjit Khangoora, MD

The faculty listed below report that they have relevant financial relationships to disclose:

• Amy Hajari Case, MD, has served on a speaker’s bureau for Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech. She has done contract research for Boehringer Ingelheim Pharmaceuticals, Inc., Bellerophon, Galapagos, Gilead, Kadmon, Kinevant, and United Therapeutics.
• Sonye Danoff, MD, PhD, has done non-CE consulting for Boehringer Ingelheim Pharmaceuticals, Inc. and Lupin. She has done contract research for Boehringer Ingelheim Pharmaceuticals, Inc., Genentech/Roche and BMS.
• Ganesh Raghu, MD, has done consulting for Avalyn, Boehringer Ingelheim Pharmaceuticals, Inc., BMS, Biogen, Bellerophon Fibrogen, Nitto, Lupin, Roche-Genentech, United Therapeutics, Veracyte, and Zambon
• Elizabeth Volkmann, MD, MS, has done non-CE consulting for Boehringer Ingelheim Pharmaceuticals, Inc. and Forbius

All relevant financial relationships listed for these individuals have been mitigated.

Instructions for Participation and Credit

How to Receive Credit:

1. There are no fees for participating in and receiving credit for this activity
2. Review the activity objectives and CME/CE information
3. Complete the CME/CE activity
4. Complete the online posttest. A score of 100% is required to successfully complete this activity. The participant may take the test until successfully passed.
5. Complete the CME/CE evaluation/attestation form. This form provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
6. Certificates will be emailed to the participant.

 

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

TFF requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter(s) assume no liability for the information herein.

Contact Information

If you have questions about this CME activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.